Nifty
Sensex
:
:
11504.95
38845.82
-11.15 (-0.10%)
-134.03 (-0.34%)

Pharmaceuticals & Drugs - Global

Rating :
64/99

BSE: 532612 | NSE: INDOCO

269.85
18-Sep-2020
  • Open
  • High
  • Low
  • Previous Close
  •  283.00
  •  290.00
  •  265.00
  •  281.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  285653
  •  790.00
  •  296.00
  •  132.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,487.14
  • 65.87
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,747.19
  • 0.11%
  • 3.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 58.69%
  • 0.00%
  • 19.63%
  • FII
  • DII
  • Others
  • 2%
  • 14.52%
  • 5.16%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.28
  • 2.47
  • -3.41

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.64
  • -14.27
  • -13.08

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.03
  • 43.67
  • 65.14

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.01
  • 3.01
  • 3.01

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.56
  • 17.20
  • 18.21

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
275.86
252.68
9.17%
271.99
0.00
0
289.35
262.64
10.17%
292.57
235.97
23.99%
Expenses
227.21
230.26
-1.32%
238.70
0.00
0
254.48
237.92
6.96%
259.94
223.84
16.13%
EBITDA
48.65
22.42
116.99%
33.29
0.00
0
34.87
24.72
41.06%
32.63
12.13
169.00%
EBIDTM
17.64%
8.87%
14.01%
0.00%
12.05%
9.41%
11.15%
5.14%
Other Income
0.26
0.64
-59.38%
0.50
0.00
0
0.72
0.56
28.57%
0.58
0.34
70.59%
Interest
5.75
6.12
-6.05%
7.83
0.00
0
6.93
3.73
85.79%
5.37
5.01
7.19%
Depreciation
19.13
16.99
12.60%
18.20
0.00
0
17.59
17.72
-0.73%
18.04
17.64
2.27%
PBT
24.03
-0.06
-
7.76
0.00
0
11.07
3.83
189.03%
9.80
-10.18
-
Tax
6.99
-1.91
-
2.40
0.00
0
1.97
-1.44
-
1.99
-2.73
-
PAT
17.04
1.85
821.08%
5.36
0.00
0
9.10
5.27
72.68%
7.81
-7.45
-
PATM
6.18%
0.73%
7.11%
0.00%
3.15%
2.01%
2.67%
-3.16%
EPS
1.85
0.20
825.00%
0.58
0.00
0
0.99
0.57
73.68%
0.85
-0.81
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Jun 06
Jun 05
Net Sales
-
968.45
1,041.94
1,074.77
1,008.12
857.32
732.61
630.79
243.43
194.15
Net Sales Growth
-
-7.05%
-3.05%
6.61%
17.59%
17.02%
16.14%
159.13%
25.38%
 
Cost Of Goods Sold
-
320.25
347.83
361.27
350.01
300.44
271.98
262.57
104.32
81.04
Gross Profit
-
648.19
694.11
713.49
658.12
556.87
460.63
368.22
139.10
113.10
GP Margin
-
66.93%
66.62%
66.39%
65.28%
64.95%
62.88%
58.37%
57.14%
58.25%
Total Expenditure
-
891.80
910.37
920.27
840.17
691.81
614.44
538.15
198.37
154.21
Power & Fuel Cost
-
28.49
26.62
23.12
21.72
20.39
18.26
16.37
7.32
4.17
% Of Sales
-
2.94%
2.55%
2.15%
2.15%
2.38%
2.49%
2.60%
3.01%
2.15%
Employee Cost
-
231.66
220.91
216.67
181.87
140.04
129.54
107.87
25.71
20.09
% Of Sales
-
23.92%
21.20%
20.16%
18.04%
16.33%
17.68%
17.10%
10.56%
10.35%
Manufacturing Exp.
-
107.07
101.94
96.38
85.18
52.92
40.58
34.30
14.25
9.22
% Of Sales
-
11.06%
9.78%
8.97%
8.45%
6.17%
5.54%
5.44%
5.85%
4.75%
General & Admin Exp.
-
110.92
110.04
116.40
102.56
90.39
83.49
66.64
25.10
22.56
% Of Sales
-
11.45%
10.56%
10.83%
10.17%
10.54%
11.40%
10.56%
10.31%
11.62%
Selling & Distn. Exp.
-
62.75
70.53
73.22
55.89
51.00
47.83
33.02
15.97
12.76
% Of Sales
-
6.48%
6.77%
6.81%
5.54%
5.95%
6.53%
5.23%
6.56%
6.57%
Miscellaneous Exp.
-
30.66
32.49
33.20
42.94
36.63
22.75
17.38
5.70
4.37
% Of Sales
-
3.17%
3.12%
3.09%
4.26%
4.27%
3.11%
2.76%
2.34%
2.25%
EBITDA
-
76.65
131.57
154.50
167.95
165.51
118.17
92.64
45.06
39.94
EBITDA Margin
-
7.91%
12.63%
14.38%
16.66%
19.31%
16.13%
14.69%
18.51%
20.57%
Other Income
-
6.15
8.05
5.93
4.03
1.71
3.97
1.50
10.02
4.81
Interest
-
20.54
23.51
6.21
12.39
10.58
18.92
21.87
5.79
3.75
Depreciation
-
71.57
67.71
63.28
60.66
47.09
30.90
23.72
6.32
4.34
PBT
-
-9.31
48.40
90.94
98.93
109.55
72.32
48.55
42.96
36.65
Tax
-
-6.41
7.24
13.87
16.99
26.73
14.28
5.79
11.47
11.61
Tax Rate
-
68.85%
14.96%
15.25%
17.17%
24.40%
19.75%
11.93%
26.70%
31.68%
PAT
-
-2.90
41.16
77.06
81.94
82.81
57.98
42.72
31.49
25.04
PAT before Minority Interest
-
-2.90
41.16
77.06
81.94
82.81
58.03
42.76
31.49
25.04
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
-0.05
-0.04
0.00
0.00
PAT Margin
-
-0.30%
3.95%
7.17%
8.13%
9.66%
7.91%
6.77%
12.94%
12.90%
PAT Growth
-
-
-46.59%
-5.96%
-1.05%
42.83%
35.72%
35.66%
25.76%
 
EPS
-
-0.31
4.46
8.36
8.89
8.98
6.29
4.63
3.42
2.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Jun 06
Jun 05
Shareholder's Funds
660.62
674.98
651.34
576.52
518.80
457.15
414.17
198.38
175.31
Share Capital
18.43
18.43
18.43
18.43
18.43
18.43
18.43
11.82
11.82
Total Reserves
642.19
656.55
632.91
558.08
500.37
438.72
395.74
186.56
163.49
Non-Current Liabilities
116.42
125.34
147.04
66.28
64.65
69.87
78.22
53.79
59.52
Secured Loans
128.66
123.28
132.31
34.24
9.42
7.20
21.41
26.45
30.37
Unsecured Loans
0.00
0.00
0.00
3.64
3.44
6.59
5.97
9.81
19.39
Long Term Provisions
15.95
23.77
30.91
40.63
15.04
16.36
6.82
0.00
0.00
Current Liabilities
445.50
417.36
390.39
302.95
262.12
202.15
199.28
58.53
50.09
Trade Payables
170.72
149.55
164.03
131.31
119.86
70.66
68.26
41.06
34.19
Other Current Liabilities
117.13
119.66
72.16
57.38
40.97
53.98
51.34
7.40
7.32
Short Term Borrowings
113.39
109.93
118.36
87.23
75.38
57.96
64.84
0.00
0.00
Short Term Provisions
44.26
38.22
35.84
27.03
25.92
19.54
14.84
10.07
8.58
Total Liabilities
1,222.54
1,217.68
1,188.77
945.75
845.57
729.42
691.87
310.70
284.92
Net Block
467.65
488.86
439.89
373.64
339.80
325.43
321.55
138.99
83.28
Gross Block
934.65
885.11
769.65
641.95
547.64
481.56
447.06
165.56
103.94
Accumulated Depreciation
467.00
396.25
329.75
268.32
207.84
156.13
125.51
26.57
20.65
Non Current Assets
684.49
678.73
616.72
481.20
460.22
424.85
416.36
143.54
96.15
Capital Work in Progress
185.43
135.56
90.63
54.80
62.71
44.12
37.78
4.55
12.86
Non Current Investment
0.02
0.02
0.02
0.02
0.17
0.17
0.12
0.00
0.00
Long Term Loans & Adv.
22.01
33.92
66.46
48.15
57.31
54.88
56.59
0.00
0.00
Other Non Current Assets
9.38
20.36
19.72
4.60
0.22
0.25
0.31
0.00
0.00
Current Assets
538.05
538.96
572.05
464.55
385.36
304.56
275.51
166.28
187.37
Current Investments
0.00
0.00
0.00
15.68
0.00
0.00
0.00
6.33
40.07
Inventories
183.45
193.38
186.94
166.69
149.12
110.22
93.18
35.60
30.11
Sundry Debtors
195.84
209.51
215.68
188.83
155.38
138.13
127.08
83.41
74.07
Cash & Bank
36.26
11.90
62.59
12.63
15.40
13.39
13.99
25.20
28.58
Other Current Assets
122.51
6.46
17.64
8.66
65.46
42.83
41.25
15.73
14.54
Short Term Loans & Adv.
106.96
117.71
89.21
72.06
61.13
38.68
35.29
15.73
14.54
Net Current Assets
92.55
121.60
181.66
161.60
123.23
102.41
76.23
107.75
137.28
Total Assets
1,222.54
1,217.69
1,188.77
945.75
845.58
729.41
691.87
310.70
284.92

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Jun 06
Jun 05
Cash From Operating Activity
132.11
122.72
88.64
113.34
109.04
98.81
68.69
36.99
6.11
PBT
-9.31
48.40
90.94
100.58
109.55
72.32
48.55
42.96
36.65
Adjustment
89.35
97.67
64.60
76.29
65.21
50.38
47.14
6.77
4.11
Changes in Working Capital
55.62
-13.23
-43.25
-36.12
-41.01
-9.16
-18.57
-5.99
-26.02
Cash after chg. in Working capital
135.66
132.83
112.29
140.75
133.75
113.53
77.12
43.73
14.74
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.55
-10.12
-23.65
-27.41
-24.71
-14.72
-8.43
-6.74
-8.63
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-103.76
-135.43
-170.55
-111.96
-88.41
-40.98
-42.61
-15.75
-89.60
Net Fixed Assets
-99.41
-160.40
-163.74
-86.39
-84.46
-40.81
-349.01
-29.62
Net Investments
0.17
0.21
15.47
-17.65
-0.19
-0.05
11.09
33.74
Others
-4.52
24.76
-22.28
-7.92
-3.76
-0.12
295.31
-19.87
Cash from Financing Activity
-16.14
-38.77
131.57
-1.48
-19.92
-58.98
-24.41
-24.61
94.50
Net Cash Inflow / Outflow
12.22
-51.48
49.66
-0.11
0.70
-1.15
1.67
-3.38
11.01
Opening Cash & Equivalents
8.58
60.06
10.40
10.47
9.77
10.92
9.25
28.58
17.57
Closing Cash & Equivalent
20.80
8.58
60.06
10.36
10.47
9.77
10.92
25.20
28.58

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Jun 06
Jun 05
Book Value (Rs.)
71.69
73.25
70.68
62.56
56.30
49.61
44.94
22.28
19.62
ROA
-0.24%
3.42%
7.22%
9.15%
10.52%
8.17%
8.53%
10.57%
8.79%
ROE
-0.43%
6.21%
12.55%
14.96%
16.97%
13.32%
13.98%
16.96%
14.40%
ROCE
1.17%
7.62%
11.80%
16.72%
20.63%
16.84%
18.33%
21.31%
18.06%
Fixed Asset Turnover
1.06
1.26
1.55
1.69
1.69
1.61
2.10
2.00
2.08
Receivable days
76.39
74.23
67.31
62.31
61.67
64.94
59.83
106.60
125.29
Inventory Days
71.01
66.40
58.84
57.17
54.49
49.80
36.61
44.48
50.93
Payable days
71.91
66.57
61.79
56.58
52.08
43.51
39.89
77.53
93.34
Cash Conversion Cycle
75.49
74.06
64.37
62.91
64.09
71.24
56.55
73.55
82.88
Total Debt/Equity
0.45
0.42
0.43
0.24
0.19
0.20
0.29
0.18
0.29
Interest Cover
0.55
3.06
15.64
8.98
11.35
4.82
3.22
8.41
10.77

News Update:


  • Indoco Remedies gets USFDA’s nod for Apixaban Tablets
    14th Sep 2020, 10:34 AM

    It is used for patients with health problems caused by a blood clot

    Read More
  • Indoco Remedies - Quarterly Results
    11th Aug 2020, 12:05 PM

    Read More
  • Indoco Remedies gets USFDA’s nod for Olanzapine Tablets
    6th Aug 2020, 10:01 AM

    Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.